Advertisement
Data breaches can happen to small medical practices

Small Practices Also at Risk for Data Breaches

0
Practices should conduct risk analysis to evaluate product deficiencies, create corrective measures
For patients with melanoma and untreated brain metastases

Nivolumab + Ipilimumab Shows Efficacy for Untreated Brain Mets

0
Findings from open-label, phase 2 study in patients with melanoma and untreated brain metastases
Prophylactic administration of tranexamic acid does not reduce postpartum hemorrhage among women with vaginal delivery receiving prophylactic oxytocin

Prophylactic Tranexamic Acid Doesn’t Cut Postpartum Bleeding

0
No significant drop in postpartum hemorrhage of 500 ml or more for women receiving oxytocin
Four more experimental treatments for Ebola virus have been approved by the Congo health ministry for use in an outbreak of the deadly infectious disease in the country's northeast.

4 Experimental Ebola Therapies Approved for Use in Congo

0
Treatments are ZMapp, Remdesivir, Favipiravir, and Regn3450 - 3471 - 3479
National Provider Identifiers are vulnerable to identity theft

National Provider Identifiers Are Vulnerable to Theft

0
Providers can take steps to prevent NPI identity theft and resulting health care fraud
The incidence of preventable adverse drug events (pADEs) is zero to 17 per 1

Preventable Adverse Drug Events Usually of Minor Severity in Kids

0
Incidence of pADEs is zero to 17 per 1,000 patient-days for children in general pediatric wards
Potential side effects of biological agents may increase anxiety in patients with rheumatic disease

Side Effects of Biologics for Rheumatic Dz May Up Anxiety

0
Common patient concerns are risks of cancer and tuberculosis activation
The American Medical Association encourages patient education to raise awareness of the risks associated with opioid use after a prolonged period of sobriety

Patient Education Urged to Prevent Opioid OD After Sobriety

0
Airlines also encouraged to include naloxone in emergency medical kits
The expiration dates of certain batches of EpiPens have been extended by the U.S. Food and Drug Administration in an effort to reduce shortages of the life-saving devices.

FDA Extends EpiPen Expiration Dates to Tackle Shortage

0
Shortages due to factors such as supply disruptions and manufacturer issues
Many low-income urban preschool-aged children with asthma do not meet the criteria for home medication readiness

Many Children With Asthma Do Not Have Medications Ready

0
Low-income urban preschoolers with asthma may not meet home medication readiness criteria